We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
-2.56%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$41.4B
AUM Growth
+$2.95B
(+7.6%)
Cap. Flow
+$4.88B
Cap. Flow
% of AUM
11.77%
Top 10 Holdings %
Top 10 Hldgs %
29.21%
Holding
888
New
32
Increased
618
Reduced
152
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$336M |
| 2 |
NVIDIA
NVDA
|
+$287M |
| 3 |
Microsoft
MSFT
|
+$284M |
| 4 |
Amazon
AMZN
|
+$199M |
| 5 |
Broadcom
AVGO
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equifax
EFX
|
+$61.7M |
| 2 |
PepsiCo
PEP
|
+$59.5M |
| 3 |
PTC
PTC
|
+$31.6M |
| 4 |
Constellation Energy
CEG
|
+$27.8M |
| 5 |
CRH
CRH
|
+$25.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.82% |
| 2 | Financials | 15.18% |
| 3 | Healthcare | 11.06% |
| 4 | Consumer Discretionary | 10.41% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
ATS Corp
ATS
$2.57B
| – | – |
-383,077
| Closed | -$11.7M |
|
|
BELFB
827
Bel Fuse Inc Class B
BELFB
$3.45B
| – | – |
-7,583
| Closed | -$625K |
|
828
Celanese
CE
$4.82B
| – | – |
-65,602
| Closed | -$4.54M |
|
829
Cricut
CRCT
$1.01B
| – | – |
-108,233
| Closed | -$617K |
|
830
Charles River Laboratories
CRL
$11.3B
| – | – |
-31,069
| Closed | -$5.74M |
|
831
Dropbox
DBX
$7.78B
| – | – |
-21,530
| Closed | -$647K |
|
832
HF Sinclair
DINO
$16.2B
| – | – |
-16,164
| Closed | -$567K |
|
833
DNOW Inc
DNOW
$2.44B
| – | – |
-41,735
| Closed | -$543K |
|
834
Enphase Energy
ENPH
$4.62B
| – | – |
-82,582
| Closed | -$5.67M |
|
835
Eagle Materials
EXP
$6.49B
| – | – |
-2,105
| Closed | -$519K |
|
836
FormFactor
FORM
$6.51B
| – | – |
-14,750
| Closed | -$649K |
|
837
Frontdoor
FTDR
$5.27B
| – | – |
-10,747
| Closed | -$588K |
|
838
VanEck Gold Miners ETF
GDX
$22.5B
| – | – |
-16,382
| Closed | -$556K |
|
839
Halozyme
HALO
$9.88B
| – | – |
-137,413
| Closed | -$6.57M |
|
840
Huntington Ingalls Industries
HII
$11B
| – | – |
-23,607
| Closed | -$4.46M |
|
841
H&R Block
HRB
$5.98B
| – | – |
-10,486
| Closed | -$554K |
|
842
Henry Schein
HSIC
$9.78B
| – | – |
-72,316
| Closed | -$5M |
|
843
Inter&Co
INTR
$2.39B
| – | – |
-139,900
| Closed | -$590K |
|
844
Innospec
IOSP
$2.09B
| – | – |
-5,181
| Closed | -$570K |
|
845
John B. Sanfilippo & Son
JBSS
$986M
| – | – |
-7,041
| Closed | -$613K |
|
846
Knight Transportation
KNX
$11.5B
| – | – |
-91,275
| Closed | -$4.84M |
|
847
Lennar Class B
LEN.B
$19.9B
| – | – |
-4,638
| Closed | -$583K |
|
848
Lamb Weston
LW
$7.42B
| – | – |
-115,629
| Closed | -$7.73M |
|
849
Lifeway Foods
LWAY
$480M
| – | – |
-25,080
| Closed | -$622K |
|
850
The Mosaic Company
MOS
$7.19B
| – | – |
-179,684
| Closed | -$4.42M |
|
Similar funds
QCM
NAMI
Aviva's Q1 2025 Portfolio in Review
As of Q1 2025, Aviva held 888 positions worth $41.4B, up 7.6% from $38.5B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Aviva deployed $4.88B of net new capital in Q1 2025, opening 32 new positions and adding to 618 existing holdings. Its largest new stake was Molson Coors Class B: 636,708 shares worth $38.8M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Equifax, an estimated $61.7M trimmed.
- Aviva's largest Q1 2025 buy was Molson Coors Class B: 636,708 shares worth $38.8M.
- Aviva added most to Apple in Q1 2025, an estimated $336M increase.
- Aviva's biggest Q1 2025 reduction was Equifax, cutting an estimated $61.7M.
- Aviva fully exited ATS Corp in Q1 2025, selling an estimated $11.7M.
- Aviva's ten largest holdings make up 29% of its $41.4B portfolio in Q1 2025.
- Aviva opened 32 new positions and closed 42 in Q1 2025.
- Aviva's portfolio value rose 7.6% quarter-over-quarter to $41.4B.
Based on Aviva's 13F filing for Q1 2025, filed 15 May 2025.